Common use of Conformity; Specifications; Quality Control Clause in Contracts

Conformity; Specifications; Quality Control. (a) All quantities of Compound supplied by Inspire pursuant to this Section 8 will comply with the Compound Specifications and applicable Manufacturing Standards and shall adhere to all applicable governmental laws and regulations relating to the manufacture, sale and shipment of each shipment of Compound at the time it is shipped by Inspire hereunder. (b) Santen shall have the right to change the Compound Specifications, from time to time, to accommodate the demands or requests of any Regulatory Authority in the Territory at any time during the term of this Agreement on not less than 12 months' prior written notice to Inspire. Inspire shall use reasonable commercial efforts to meet such changes. In addition, other changes to the Compound Specifications shall be made only upon the mutual consent of the Parties. Any costs or expenses incurred by Inspire in connection with such changes shall be borne by Santen, and Inspire shall be entitled to include such costs and expenses in invoices submitted to Santen pursuant to Section 7.1(a), from time to time. (c) Inspire shall conduct, or cause to be conducted, quality control testing of Compound prior to shipment, in accordance with the Compound Specifications and applicable Manufacturing Standards as are in effect from time to time and such other quality control testing procedures agreed to by the Parties from time to time (collectively, the "Testing Methods"

Appears in 2 contracts

Sources: Development, License and Supply Agreement (Inspire Pharmaceuticals Inc), Development, License and Supply Agreement (Inspire Pharmaceuticals Inc)

Conformity; Specifications; Quality Control. (a) All quantities of Compound Supplied Goods supplied by Inspire pursuant to this Section 8 the Supply Agreement will comply with the Compound all applicable Specifications and applicable Manufacturing Standards and shall adhere to all applicable governmental laws and regulations relating to the manufacture, sale and shipment of each shipment of Compound the respective Supplied Goods at the time it is shipped they arrive at the point designated by Inspire hereunderKissei. (b) Santen Kissei shall have the right to change the Compound Specifications, from time to time, to accommodate the demands or requests of any Regulatory Authority in the Territory at any time during the term of this the Supply Agreement on not less than 12 months' prior written notice to Inspire. Inspire shall use reasonable commercial efforts to meet such changes. In addition, other changes to the Compound Specifications shall be made only upon the mutual consent of the Parties. Any costs or expenses incurred by Inspire in connection with such changes shall be borne by SantenKissei, and Inspire shall be entitled to include such costs and expenses in invoices submitted to Santen Kissei pursuant to Section 7.1(a)) of the License Agreement, from time to time. In addition, other changes to the Specifications shall be made only upon the mutual consent of the Parties. In this case, any costs or expenses derived from such changes shall be paid by the Party which demands or requests such changes. In any such event, Inspire shall use reasonable commercial efforts to meet any of the foregoing changes. (c) Inspire shall conduct, or cause to be conducted, quality control testing of Compound Supplied Goods prior to shipment, shipment in accordance with the Compound applicable Specifications and applicable Manufacturing Standards as are in effect from time to time and such other quality control testing procedures agreed to by the Parties from time to time (collectively, the "Testing Methods"

Appears in 1 contract

Sources: Joint Development, License and Supply Agreement (Inspire Pharmaceuticals Inc)